Veröffentlichungen 2007


1. Andriopoulos B, Hegedüsch S, Mangin J, Riedel HD, Hebling U, Wang J, Pantopoulos K, Mueller S. Sustained hydrogen peroxide induces iron uptake by transferrin receptor-1 independent of the iron regulatory protein/iron-responsive element network. J Biol Chem 2007;282(28):20301-8.

2. Benck U, Haeckel S, Clorius JH, van der Woude FJ. Proteinuria-Lowering Effect of Heparin Therapy in Diabetic Nephropathy without Affecting the Renin-Angiotensin-Aldosterone System. Clin J Am Soc Nephrol 2007;2:58-67.

3. Buchmann I, Henze M, Engelbrecht S, Eisenhut M, Runz A, Schafer M, Schilling T, Haufe S, Herrmann T, Haberkorn U. Comparison of (68)Ga-DOTATOC PET and (111)In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2007;34(10):1617-26.

4. Buchmann I, Riedmüller K, Hoffner S, Mack U, Aulmann S, Haberkorn U. Comparison of 99mTechnetium-pertechnetate and 123Iodide SPECT with FDG-PET in Patients Suspicious for Breast Cancer. Cancer Biother Radiopharm 2007;22(6):779-789.

5. Dimitrakopoulou-Strauss A, Hohenberger P, Haberkorn U, Mäcke HR, Eisenhut M, Strauss LG. 68Ga-Labeled Bombesin Studies in Patients with Gastrointestinal Stromal Tumors: Comparison with 18F-FDG. J Nucl Med 2007;48:1245-1250.

6. Dimitrakopoulou-Strauss A, Hoffmann M, Bergner R, Uppenkamp M, Eisenhut M, Pan L, Haberkorn U, Strauss LG. Prediction of Short-term Survival in Patients with Advanced Nonsmall Cell Lung Cancer Following Chemotherapy Based on 2-Deoxy-2-[F-18]fluoro-D: -glucose-Positron Emission Tomography: A Feasibility Study. Mol Imaging Biol 2007;9:308-17.

7. Dimitrakopoulou-Strauss A, Hohenberger P, Strobel P, Marx A, Strauss LG. A recent application of fluoro-18-deoxyglucose positron emission tomography, treatment monitoring with a mammalian target of rapamycin inhibitor: an example of a patient with a desmoplastic small round cell tumor. Hell J Nucl Med 2007;10(2):77-9.

8. Frank-Raue K, Fabel M, Delorme S, Haberkorn U, Raue F. Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma. Eur J Endocrinol 2007;157(2):215-220.

9. Garcia Boy R, Haberkorn U, Mier W. Stabilisation of small proteins for their use as pharmacological scaffolds – why knot? Chemistry today 2007; 25(3):36-39.

10. Graham K, Wang Q, Garcia Boy R, Eisenhut M, Haberkorn U, Mier W. Synthesis and evaluation of intercalating somatostatin receptor binding peptide conjugates for endoradiotherapy. J Pharm Pharm Sci. 2007;10(2):286s-297s.

11. Haberkorn U. Genomics und Proteomics in der Nuklearmedizin. Der Nuklearmediziner 2007;30:11-18.

12. Haberkorn U. Pancreatic cancer – Diagnostics: PET. Chinese German J Clin Oncol 2007;6(2):117-122.

13. Haberkorn U, Hoffend J, Schmidt K, Altmann A, Bonaterra GA, Dimitrakopoulou-Strauss A, Strauss LG, Eisenhut M, Kinscherf R. Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma. Eur J Nucl Med Mol Imaging 2007;34(12):2011-23.

14. Haberkorn U, Altmann A, Mier W, Eisenhut M. Molecular imaging of tumor me-tabolism and apoptosis. Ernst Schering Found Symp Proc 2007;(4):125-152.

15. Hempfing A, Hoffend J, Bitsch RG, Bernd L. The indication for gamma probe-guided surgery of spinal osteoid osteomas. Eur Spine J 2007;16(10):1668-1672.

16. Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J. Reduced cerebral glucose metabolism in patients at risk of developing Alzheimer's disease. Psych Res Neuroim 2007;155(2):147-154.

17. Kasper B, Egerer G, Gronkowski M, Haufe S, Lehnert T, Eisenhut M, Mechtersheimer G, Ho AD, Haberkorn U. Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET. Leukemia and Lymphoma 2007;48(4):746-753.

18. Kirin SI, Noor F, Metzler-Nolte N, Mier W. Manual solid phase peptide synthesis of metallocene-peptide bioconjugates. J Chem Educ 2007;84:108-111.

19. Kristen AV, Ehlermann P, Helmke B, Hund E, Haberkorn U, Linke RP, Katus HA, Winter P, Altland K, Dengler TJ. Transthyretin valine-94-alanine, a novel variant associated with late-onset systemic amyloidosis with cardiac involvement. Amyloid 2007;14(4):283-7.

20. Mier W, Zitzmann S, Kramer S, Reed J, Knapp EM, Altmann A, Eisenhut M, Haberkorn U. Influence of Chelate Conjugation on a Newly Identified Tumor-Targeting Peptide. J Nucl Med 2007;48:1545-1552.

21. Munter MW, Hoffner S, Hof H, Herfarth KK, Haberkorn U, Rudat V, Huber P, Debus J, Karger CP. Changes in salivary gland function after radiotherapy of head-and-neck tumors measured by quantitative pertechnetate scintigraphy: Comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int J Radiat Oncol Biol Phys 2007;6(3):651-659.

22. Sabbir Ahmed ASM, Dimitrakopoulou-Strauss A, Strauss LG, Pan P, Semmler W, Peter J. Validation study of a 3 Compartment Model for 18F-FDG. PET Studies on Oncology Patients. World J Nucl Med 2007;6:107-116.

23. Strauss LG, Klippel S, Pan L, Schönleben K, Haberkorn U, Dimitrakopoulou-Strauss A. Assessment of quantitative PET FDG data in primary colorectal tumours: which parameters are important with respect to the tumour detection? Eur J Nucl Med Mol Imaging 2007;34:868-877.

24. Strauss LG, Pan L, Koczan D, Klippel S, Mikolajczyk K, Burger C, Haberkorn U, Schönleben K, Thiesen HJ, Dimitrakopoulou-Strauss A. Fusion of positron emission tomography (PET) and gene array data: a new approach for the correlative analysis of molecular biological and clinical data. IEEE Trans Med Imaging 2007;26(6):804-812.

25. Strauss LG, Dimitrakopoulou-Strauss A. Can PET-CT with FDG replace contrast enhanced CT for imaging of liver metastases? Eur J Nucl Med Mol Imaging 2007;34:1902-1905.

26. Utikal J, Ugurel S, Kurzen H, Erben P, Reiter A, Hochhaus A, Nebe T, Hildenbrand R, Haberkorn U, Goerdt S, Schadendorf D. Imatinib as a Treatment Option for Systemic Non-Langerhans Cell Histiocytosis. Arch Dermatol 2007;143:736-740.

27. Wängler C, Buchmann I, Eisenhut M, Haberkorn, U, Mier W. Radiolabeled peptides and proteins in cancer therapy. Protein Pept Lett 2007;14(3):273-9.

28. Wolf M, Hull WE, Mier W, Heiland S, Bauder-Wust U, Kinscherf R, Haberkorn U, Eisenhut M. Polyamine-Substituted Gadolinium Chelates: A New Class of Intracellular Contrast Agents for Magnetic Resonance Imaging of Tumors. J Med Chem 2007;11;50(1):139-148.

29. Wolf M, Bauder-Wust U, Eskerski H, Bauer C, Eisenhut M. Role of acidic cell organelles in the higher nonmelanoma retention of melanoma markers based on N-(2-dialkylaminoethyl)benzamides and the cytotoxicity of alkylating benzamides. Melanoma Res 2007;17:61-73.

30. Zitzmann S, Kramer S, Mier W, Hebling U, Altmann A, Rother A, Berndorff D, Eisenhut M, Haberkorn U. Identification and Evaluation of a New Tumor Cell-Binding Peptide, FROP-1. J Nucl Med 2007;48:965-972.


1. Dimitrakopoulou-Strauss A, Hoffmann M, Uppenkamp M, Rudi J, Eisenhut M, Haberkorn U, Strauss LG. Therapy monitoring based on FDG-PET follow-up studies for the prediction of individual survival. In: International Conference on Clinical PET and Molecular Nuclear Medicine, Book of Extended Synopses. Hrsg.: IAEA-CN-157, 2007, pp 128-129.

2. Dimitrakopoulou-Strauss A, Hohenberger P, Koukouraki S, Georgoulias V, Eisenhut M, Mäcke HR, Haberkorn U, Strauss LG. Use of Ga-68-DOTATOC labeled peptides and PET for diagnosis and therapy monitoring in oncological patients. In: International Conference on Clinical PET and Molecular Nuclear Medicine, Book of Extended Synopses. Hrsg.: IAEA-CN-157, 2007, pp 210-211.

3. Strauss LG, Klippel S, Koczan D, Pan L, Cheng C, Haberkorn U, Dimitrakopoulou-Strauss A. Fusion of PET and molecular biology: combined assessment of quantitative dynamic PET data and gene array results using GenePET software. In: International Conference on Clinical PET and Molecular Nuclear Medicine, Book of Extended Synopses. Hrsg.: IAEA-CN-157, 2007, pp 288-289.

4. Strauss LG, Koczan D, Pan L, Cheng C, Haberkorn U, Dimitrakopoulou-Strauss A. Quantitative dynamic PET for the detection and differentiation of bone lesions. In: International Conference on Clinical PET and Molecular Nuclear Medicine, Book of Extended Synopses. Hrsg.: IAEA-CN-157, 2007, pp 290-291.

nach oben